(BILI) Bilibili - Ratings and Ratios
Exchange: NASDAQ •
Country: China •
Currency: USD •
Type: Common Stock •
ISIN: US0900401060
Video, Gaming, Live, Ads, Merchandise
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 60.7% |
| Value at Risk 5%th | 89.8% |
| Relative Tail Risk | -9.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 4.63 |
| CAGR/Max DD | 0.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.466 |
| Beta | 1.025 |
| Beta Downside | 1.606 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.38% |
| Mean DD | 37.75% |
| Median DD | 39.31% |
Description: BILI Bilibili November 03, 2025
Bilibili Inc. (NASDAQ:BILI) is a Shanghai-based platform that delivers online entertainment to China’s younger generations. Its ecosystem combines user-generated video, mobile gaming, live streaming, audio dramas, comics, and advertising services, while also venturing into e-commerce and IP-based merchandise.
Key recent metrics (as of Q2 2024) include 241 million monthly active users (MAU), a 21 % YoY increase in total revenue to $1.18 billion, and an average revenue per user (ARPU) of roughly $4.90. Growth is being driven by rising discretionary spend among Chinese Gen-Z consumers, the gradual recovery of the mobile gaming market after regulatory tightening, and expanding ad spend on short-form video formats. However, the company remains exposed to regulatory risk (e.g., content censorship) and macro-economic headwinds that could affect advertising budgets.
If you want a data-rich, side-by-side comparison of Bilibili’s valuation and risk profile, ValueRay’s platform offers a granular dashboard that can help you assess whether the stock’s upside justifies its current price.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (770.1m TTM) > 0 and > 6% of Revenue (6% = 1.79b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -1.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 35.36% (prev 3.66%; Δ 31.71pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.29b > Net Income 770.1m (YES >=105%, WARN >=100%) |
| Net Debt (-5.10b) to EBITDA (933.4m) ratio: -5.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (413.7m) change vs 12m ago -1.56% (target <= -2.0% for YES) |
| Gross Margin 36.36% (prev 30.05%; Δ 6.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 82.72% (prev 79.47%; Δ 3.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.23 (EBITDA TTM 933.4m / Interest Expense TTM 130.2m) >= 6 (WARN >= 3) |
Altman Z'' -1.64
| (A) 0.26 = (Total Current Assets 27.00b - Total Current Liabilities 16.48b) / Total Assets 39.93b |
| (B) -0.69 = Retained Earnings (Balance) -27.61b / Total Assets 39.93b |
| (C) 0.00 = EBIT TTM 159.9m / Avg Total Assets 35.98b |
| (D) -1.09 = Book Value of Equity -27.35b / Total Liabilities 25.04b |
| Total Rating: -1.64 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.50
| 1. Piotroski 5.50pt |
| 2. FCF Yield 4.82% |
| 3. FCF Margin 11.06% |
| 4. Debt/Equity 0.35 |
| 5. Debt/Ebitda -5.47 |
| 6. ROIC - WACC (= -8.46)% |
| 7. RoE 5.35% |
| 8. Rev. Trend 83.17% |
| 9. EPS Trend 95.51% |
What is the price of BILI shares?
As of December 14, 2025, the stock is trading at USD 24.60 with a total of 3,111,665 shares traded.
Over the past week, the price has changed by -4.65%, over one month by -9.53%, over three months by -3.34% and over the past year by +21.48%.
Over the past week, the price has changed by -4.65%, over one month by -9.53%, over three months by -3.34% and over the past year by +21.48%.
Is BILI a buy, sell or hold?
Bilibili has received a consensus analysts rating of 4.45.
Therefore, it is recommended to buy BILI.
- Strong Buy: 19
- Buy: 7
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BILI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.1 | 22.2% |
| Analysts Target Price | 30.1 | 22.2% |
| ValueRay Target Price | 25.2 | 2.5% |
BILI Fundamental Data Overview December 08, 2025
Market Cap CNY = 75.29b (10.67b USD * 7.0548 USD.CNY)
P/E Trailing = 99.2308
P/E Forward = 27.027
P/S = 0.3586
P/B = 5.0658
Beta = 0.722
Revenue TTM = 29.76b CNY
EBIT TTM = 159.9m CNY
EBITDA TTM = 933.4m CNY
Long Term Debt = 8.06b CNY (from longTermDebt, last quarter)
Short Term Debt = 1.64b CNY (from shortLongTermDebt, last quarter)
Debt = 5.15b CNY (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -5.10b CNY (from netDebt column, last fiscal year)
Enterprise Value = 68.34b CNY (75.29b + Debt 5.15b - CCE 12.10b)
Interest Coverage Ratio = 1.23 (Ebit TTM 159.9m / Interest Expense TTM 130.2m)
FCF Yield = 4.82% (FCF TTM 3.29b / Enterprise Value 68.34b)
FCF Margin = 11.06% (FCF TTM 3.29b / Revenue TTM 29.76b)
Net Margin = 2.59% (Net Income TTM 770.1m / Revenue TTM 29.76b)
Gross Margin = 36.36% ((Revenue TTM 29.76b - Cost of Revenue TTM 18.94b) / Revenue TTM)
Gross Margin QoQ = 36.67% (prev 36.47%)
Tobins Q-Ratio = 1.71 (Enterprise Value 68.34b / Total Assets 39.93b)
Interest Expense / Debt = 0.82% (Interest Expense 42.1m / Debt 5.15b)
Taxrate = -3.25% (negative due to tax credits) (-14.8m / 454.6m)
NOPAT = 165.1m (EBIT 159.9m * (1 - -3.25%)) [negative tax rate / tax credits]
Current Ratio = 1.64 (Total Current Assets 27.00b / Total Current Liabilities 16.48b)
Debt / Equity = 0.35 (Debt 5.15b / totalStockholderEquity, last quarter 14.90b)
Debt / EBITDA = -5.47 (Net Debt -5.10b / EBITDA 933.4m)
Debt / FCF = -1.55 (Net Debt -5.10b / FCF TTM 3.29b)
Total Stockholder Equity = 14.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.93% (Net Income 770.1m / Total Assets 39.93b)
RoE = 5.35% (Net Income TTM 770.1m / Total Stockholder Equity 14.39b)
RoCE = 0.71% (EBIT 159.9m / Capital Employed (Equity 14.39b + L.T.Debt 8.06b))
RoIC = 0.76% (NOPAT 165.1m / Invested Capital 21.75b)
WACC = 9.22% (E(75.29b)/V(80.44b) * Re(9.79%) + D(5.15b)/V(80.44b) * Rd(0.82%) * (1-Tc(-0.03)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.14%
[DCF Debug] Terminal Value 75.98% ; FCFE base≈3.22b ; Y1≈3.98b ; Y5≈6.78b
Fair Price DCF = 254.9 (DCF Value 84.89b / Shares Outstanding 333.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 95.51 | EPS CAGR: 69.67% | SUE: 1.58 | # QB: 1
Revenue Correlation: 83.17 | Revenue CAGR: 7.89% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.30 | Chg30d=-0.207 | Revisions Net=-3 | Analysts=4
EPS next Year (2026-12-31): EPS=7.90 | Chg30d=+0.169 | Revisions Net=+6 | Growth EPS=+37.5% | Growth Revenue=+9.6%
P/E Trailing = 99.2308
P/E Forward = 27.027
P/S = 0.3586
P/B = 5.0658
Beta = 0.722
Revenue TTM = 29.76b CNY
EBIT TTM = 159.9m CNY
EBITDA TTM = 933.4m CNY
Long Term Debt = 8.06b CNY (from longTermDebt, last quarter)
Short Term Debt = 1.64b CNY (from shortLongTermDebt, last quarter)
Debt = 5.15b CNY (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -5.10b CNY (from netDebt column, last fiscal year)
Enterprise Value = 68.34b CNY (75.29b + Debt 5.15b - CCE 12.10b)
Interest Coverage Ratio = 1.23 (Ebit TTM 159.9m / Interest Expense TTM 130.2m)
FCF Yield = 4.82% (FCF TTM 3.29b / Enterprise Value 68.34b)
FCF Margin = 11.06% (FCF TTM 3.29b / Revenue TTM 29.76b)
Net Margin = 2.59% (Net Income TTM 770.1m / Revenue TTM 29.76b)
Gross Margin = 36.36% ((Revenue TTM 29.76b - Cost of Revenue TTM 18.94b) / Revenue TTM)
Gross Margin QoQ = 36.67% (prev 36.47%)
Tobins Q-Ratio = 1.71 (Enterprise Value 68.34b / Total Assets 39.93b)
Interest Expense / Debt = 0.82% (Interest Expense 42.1m / Debt 5.15b)
Taxrate = -3.25% (negative due to tax credits) (-14.8m / 454.6m)
NOPAT = 165.1m (EBIT 159.9m * (1 - -3.25%)) [negative tax rate / tax credits]
Current Ratio = 1.64 (Total Current Assets 27.00b / Total Current Liabilities 16.48b)
Debt / Equity = 0.35 (Debt 5.15b / totalStockholderEquity, last quarter 14.90b)
Debt / EBITDA = -5.47 (Net Debt -5.10b / EBITDA 933.4m)
Debt / FCF = -1.55 (Net Debt -5.10b / FCF TTM 3.29b)
Total Stockholder Equity = 14.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.93% (Net Income 770.1m / Total Assets 39.93b)
RoE = 5.35% (Net Income TTM 770.1m / Total Stockholder Equity 14.39b)
RoCE = 0.71% (EBIT 159.9m / Capital Employed (Equity 14.39b + L.T.Debt 8.06b))
RoIC = 0.76% (NOPAT 165.1m / Invested Capital 21.75b)
WACC = 9.22% (E(75.29b)/V(80.44b) * Re(9.79%) + D(5.15b)/V(80.44b) * Rd(0.82%) * (1-Tc(-0.03)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.14%
[DCF Debug] Terminal Value 75.98% ; FCFE base≈3.22b ; Y1≈3.98b ; Y5≈6.78b
Fair Price DCF = 254.9 (DCF Value 84.89b / Shares Outstanding 333.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 95.51 | EPS CAGR: 69.67% | SUE: 1.58 | # QB: 1
Revenue Correlation: 83.17 | Revenue CAGR: 7.89% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.30 | Chg30d=-0.207 | Revisions Net=-3 | Analysts=4
EPS next Year (2026-12-31): EPS=7.90 | Chg30d=+0.169 | Revisions Net=+6 | Growth EPS=+37.5% | Growth Revenue=+9.6%
Additional Sources for BILI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle